Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: HIV infection in adolescents".)

●(See "Society guideline links: Primary care of adults with HIV".)

●(See "Society guideline links: Sexually transmitted infections".)

●(See "Society guideline links: Immunizations in patients with HIV".)

●(See "Society guideline links: HIV treatment in pregnant women".)

●(See "Society guideline links: Solid organ transplantation in individuals with HIV".)

●(See "Society guideline links: Acute diarrhea in adults".)

●(See "Society guideline links: Aspergillosis".)

●(See "Society guideline links: Candidiasis".)

●(See "Society guideline links: Chagas disease".)

●(See "Society guideline links: Coccidioidomycosis".)

●(See "Society guideline links: Cryptococcosis".)

●(See "Society guideline links: Management of hepatitis B".)

●(See "Society guideline links: Hepatitis C virus infection".)

●(See "Society guideline links: Molluscum contagiosum".)

●(See "Society guideline links: Nontuberculous mycobacteria".)

●(See "Society guideline links: Toxoplasmosis".)

●(See "Society guideline links: Diagnosis and treatment of tuberculosis".)

●(See "Society guideline links: Histoplasmosis".)

●(See "Society guideline links: HIV treatment in nonpregnant adults and adolescents".)

International

●Pan American Health Organization (PAHO): Guidelines for diagnosing and managing disseminated histoplasmosis among people living with HIV (2020)

●World Health Organization (WHO): Guidelines for diagnosing and managing disseminated histoplasmosis among people living with HIV (2020)

●WHO: Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children – Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2018)

●WHO: Guidelines for treatment of drug-susceptible tuberculosis and patient care, update (2017)

●WHO: Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations, update (2016)

●WHO: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection – Recommendations for a public health approach, second edition (2016)

●WHO: Guidelines for the prevention, care, and treatment of persons with chronic hepatitis B infection (2015)

●WHO: Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children – Recommendations for a public health approach: Supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2014)

●WHO: Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults (2014)

Canada

●Canadian Lung Association (CLA) and the Public Health Agency of Canada (PHAC): Canadian Tuberculosis Standards, 7th edition – Tuberculosis and human immunodeficiency virus (2014)

United States

●Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA): Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV

●American Academy of Pediatrics (AAP): Red Book – Human immunodeficiency virus infection (2021)

●CDC: Sexually transmitted infections treatment guidelines (2021)

●International Antiviral Society–USA Panel (IAS-USA): Recommendations on antiretroviral drugs for treatment and prevention of HIV infection in adults (2020)

●Choosing Wisely: Don't routinely order testing for glucose-6-phosphate dehydrogenase (G6PD) deficiency for patients who are not predisposed due to race/ethnicity (2016)

●Choosing Wisely: Don't routinely test for CMV IgG in HIV-infected patients who have a high likelihood of being infected with CMV (2016)

Europe

●European AIDS Clinical Society (EACS): Guidelines (2020)

United Kingdom

●British HIV Association (BHIVA): Current guidelines

Australia-New Zealand

●Australasian Society for HIV Medicine (ASHM): Antiretroviral guidelines – Considerations for antiretroviral use in patients with coinfections

•Hepatitis C virus/HIV coinfection (2018)

•Hepatitis B virus/HIV coinfection (2017)

•Mycobacterium tuberculosis disease with HIV coinfection (2016)